Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 2Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Invasive Fungal Infections 1Hematologic Neoplasms 1

Interventions

Filgrastim 4Etoposide 3Cytarabine 2Carboplatin 2pegfilgrastim 1liposomal amphotericin B 1Vincristine 1Thrombopoietin 1Thioguanine 1Taxes 1Radiotherapy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Moxifloxacin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Leucovorin 1Ifosfamide 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Epirubicin 1Doxorubicin 1Docetaxel 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neutropenia × Fluconazole × Clear all
NCT01307579 2021-03-30

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Children's Oncology Group

Phase 3 Completed
517 enrolled 14 charts
Other hematologic neoplasm

Invasive Fungal Infections, Leukemia, Leukemia, Monocytic, Acute, Mycoses, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡